Veeva Systems A reported second-quarter adjusted earnings per share of $2.35, exceeding the $2.22 consensus estimate by $0.13. Revenue totaled $927.96 million, surpassing the $905.41 million estimate.
The company, which provides cloud-based software for life sciences, also raised its guidance for the third quarter and full fiscal year. Third-quarter adjusted EPS is projected at $2.33-$2.34, above the $2.28 consensus. Revenue guidance for the quarter was set at $932.0-$935.0 million, compared with the $917.9 million estimate. For the full fiscal year ending January 2027, Veeva now expects revenue of $3.68-$3.69 billion, up from the prior consensus of $3.65 billion.
The stock closed at $244.91, up 40.48% over the past three months but down 16.58% year-over-year. Over the last 90 days, 21 analysts revised earnings estimates upward while three issued downward revisions. Financial health metrics rated the company’s performance as strong according to InvestingPro.
